The U.S. is imposing new rules on ordering synthetic DNA to deter bioterrorism, with the policy apparently affecting government-funded researchers and suppliers. Commenters question how much supply-side restrictions will help, noting that DNA manipulation is not especially difficult and determined actors may find workarounds. Some also speculate about whether restrictions relate to hidden AI biotech capabilities, but the discussion offers no clear evidence.